THE ANTI-FIBROTIC ACTIONS OF RELAXIN ARE MEDIATED THROUGH A NO-sGC-cGMP-DEPENDENT PATHWAY IN RENAL MYOFIBROBLASTS IN VITRO AND ENHANCED BY THE NO DONOR, DIETHYLAMINE NONOATE
INTRODUCTION: The anti-fibrotic hormone, relaxin, has been inferred to disrupt TGF-beta1/Smad2 phosphorylation (pSmad2) signal transduction and promote collagen-degrading gelatinase activity via a nitric oxide (NO)-dependent pathway. Here, we determined the extent to which NO, soluble guanylate cycl...
Saved in:
Main Authors: | Chao eWang (Author), Barbara Kathryn Kemp-Harper (Author), Martina eKocan (Author), Sheng Yu eAng (Author), Tim David Hewitson (Author), Chrishan S Samuel (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
by: Anita A. Pinar, et al.
Published: (2020) -
Memory Enhancers for Alzheimer's Dementia: Focus on cGMP
by: Ernesto Fedele, et al.
Published: (2021) -
Redox regulation of cGMP-dependent protein kinase Iα in the cardiovascular system
by: Oleksandra ePrysyazhna, et al.
Published: (2015) -
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
by: Jens Schlossmann, et al.
Published: (2013) -
L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway
by: I. D. G. Duarte, et al.
Published: (2000)